Dishman Carbogen Amcis net revenue stands at Rs 541 crores for Q1 FY23 \
3 min read
\
\

Dishman Carbogen Amcis net revenue stands at Rs 541 crores for Q1 FY23

11-Aug-2022
Ahmedabad (Gujarat) [India], August 11 (ANI/PNN): Dishman Carbogen Amcis Ltd, a fully integrated CRAMS (Contract Research and Manufacturing) company with strong capabilities right from process research and development to late-stage clinical and commercial manufacturing and supply of API to innovator pharmaceutical companies, have announced their first quarter (Q1FY23) results.
11-Aug-2022 Business
\